Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
AssigneeSchering Corporation
InventorsTze-Ming Chan, Kathleen Cox, Wenqing Feng, Michael Miller, Daniel Weston, Stuart McCombie
Life of this patent
Estimating the term…
Loading patent…
AssigneeSchering Corporation
InventorsTze-Ming Chan, Kathleen Cox, Wenqing Feng, Michael Miller, Daniel Weston, Stuart McCombie
Estimating the term…
In its many embodiments, the present invention provides a novel class of compounds of structural formula IA or IB where R1-R8 are as disclosed herein as inhibitors of the CCR5 receptors, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with CCR5 using such compounds or pharmaceutical compositions. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
A compound represented by the structural formula IA
A compound in isolated and pure form, said compound represented by the structural formula IB
A process for preparing a compound represented by the structural formula IC:
Dependencies are inferred from the claim text.